Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers

被引:15
作者
Im, Kate M. [2 ]
Kirchhoff, Tomas [3 ]
Wang, Xianshu [4 ]
Green, Todd [5 ,6 ,7 ]
Chow, Clement Y. [8 ]
Vijai, Joseph [3 ]
Korn, Joshua [5 ,6 ,7 ]
Gaudet, Mia M. [9 ]
Fredericksen, Zachary [4 ]
Pankratz, V. Shane [4 ]
Guiducci, Candace [5 ,6 ,7 ]
Crenshaw, Andrew [5 ,6 ,7 ]
McGuffog, Lesley [10 ]
Kartsonaki, Christiana [10 ]
Morrison, Jonathan [10 ]
Healey, Sue [11 ]
Sinilnikova, Olga M. [12 ,13 ]
Mai, Phuong L. [14 ]
Greene, Mark H. [14 ]
Piedmonte, Marion [15 ]
Rubinstein, Wendy S. [16 ]
Hogervorst, Frans B. [17 ]
Rookus, Matti A. [18 ]
Collee, J. Margriet [5 ,19 ]
Hoogerbrugge, Nicoline [20 ]
van Asperen, Christi J.
Meijers-Heijboer, Hanne E. J. [21 ]
van Roozendaal, Cees E. [22 ]
Caldes, Trinidad [23 ]
Perez-Segura, Pedro [23 ]
Jakubowska, Anna [24 ]
Lubinski, Jan [24 ]
Huzarski, Tomasz [24 ]
Blecharz, Pawel [25 ]
Nevanlinna, Heli [26 ]
Aittomaki, Kristiina [27 ]
Lazaro, Conxi [28 ]
Blanco, Ignacio [28 ]
Barkardottir, Rosa B. [29 ,30 ]
Montagna, Marco [5 ,31 ]
D'Andrea, Emma [31 ,32 ]
Devilee, Peter [33 ]
Olopade, Olufunmilayo I. [34 ]
Neuhausen, Susan L. [35 ]
Peissel, Bernard [36 ]
Bonanni, Bernardo [37 ]
Peterlongo, Paolo [38 ,39 ]
Singer, Christian F. [40 ,41 ]
Rennert, Gad [42 ]
Lejbkowicz, Flavio [42 ]
机构
[1] NCI, Frederick, MD 21702 USA
[2] NCI, Ctr Canc Res, Canc Inflammat Program, Human Genet Sect, Frederick, MD 21701 USA
[3] Mem Sloan Kettering Canc Ctr, Clin Genet Serv, Dept Med, Program Canc Prevent & Populat Res,Program Canc P, New York, NY 10021 USA
[4] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
[5] Harvard Univ, Sch Med, Dept Genet & Med, Boston, MA USA
[6] Harvard Univ, Program Med & Populat Genet, Broad Inst, Cambridge, MA 02138 USA
[7] Massachusetts Gen Hosp, Dept Mol Biol, Ctr Human Genet Res, Boston, MA 02114 USA
[8] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA
[9] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA
[10] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England
[11] Queensland Inst Med Res, Genet & Populat Hlth Div, Brisbane, Qld 4006, Australia
[12] Ctr Hosp Univ Lyon, Unite Mixte Genet Constitut Canc Frequents, Ctr Lyon Berard, Lyon, France
[13] Univ Lyon, Ctr Leon Berard, Lyon, France
[14] NCI, Clin Genet Branch, Rockville, MD USA
[15] Roswell Pk Canc Inst, GOG Stat & Data Ctr, Buffalo, NY 14263 USA
[16] NorthShore Univ Hlth Syst, Evanston, IL USA
[17] Netherlands Canc Inst, Family Canc Clin, Amsterdam, Netherlands
[18] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands
[19] Erasmus Univ, Dept Clin Genet, Family Canc Clin, Med Ctr, NL-3000 DR Rotterdam, Netherlands
[20] Radboud Univ Nijmegen, Hereditary Canc Clin, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[21] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Leiden, Netherlands
[22] Univ Med Ctr, Dept Clin Genet, Maastricht, Netherlands
[23] Hosp Clin San Carlos, Mol Oncol Lab, Madrid, Spain
[24] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland
[25] Maria Sklodowska Curie Mem Inst Oncol, Ctr Oncol, Krakow, Poland
[26] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland
[27] Univ Helsinki, Cent Hosp, Dept Clin Genet, FIN-00290 Helsinki, Finland
[28] Catalan Inst Oncol IDIBELL, Hereditary Canc Program, Barcelona, Spain
[29] Landspitali LSH, Dept Pathol, Reykjavik, Iceland
[30] Univ Iceland, Fac Med, Reykjavik, Iceland
[31] IRCCS, Immunol & Mol Oncol Unit, Ist Oncol Veneto IOV, Padua, Italy
[32] Univ Padua, Dept Oncol & Surg Sci, Padua, Italy
[33] Leiden Univ, Dept Human Genet & Pathol, Med Ctr, Leiden, Netherlands
[34] Univ Chicago, Med Ctr, Ctr Clin Canc Genet & Global Hlth, Dept Med, Chicago, IL 60637 USA
[35] Beckman Res Inst City Hope, Dept Populat Sci, Duarte, CA USA
[36] Fdn IRCCS Ist Nazl Tumori INT, Unit Med Genet, Dept Prevent & Predict Med, Milan, Italy
[37] IEO, Div Canc Prevent & Genet, Milan, Italy
[38] Fdn IRCCS Ist Nazl Tumori INT, Unit Genet Susceptibil Canc, Dept Expt Oncol & Mol Med, Milan, Italy
[39] Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy
[40] Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria
[41] Univ Vienna, Comprehens Canc Med Ctr, Vienna, Austria
[42] Carmel Hosp, CHS Natl Canc Control Ctr, Haifa, Israel
[43] Carmel Hosp, Dept Community Med & Epidemiol, Haifa, Israel
[44] Technion Israel Inst Technol, Fac Med, Haifa, Israel
[45] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
[46] Univ Toronto, Genet Network, Toronto, ON, Canada
[47] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada
[48] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA
[49] Univ Pisa, Sect Genet Oncol, Dept Lab Med, Pisa, Italy
[50] Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA USA
基金
澳大利亚国家健康与医学研究理事会; 美国国家卫生研究院;
关键词
TAY-SACHS DISEASE; BREAST-CANCER; POSITIVE SELECTION; GENOME; FREQUENCY; SIGNATURES; HISTORY; RISK; JEWS;
D O I
10.1007/s00439-011-1003-z
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Three founder mutations in BRCA1 and BRCA2 contribute to the risk of hereditary breast and ovarian cancer in Ashkenazi Jews (AJ). They are observed at increased frequency in the AJ compared to other BRCA mutations in Caucasian non-Jews (CNJ). Several authors have proposed that elevated allele frequencies in the surrounding genomic regions reflect adaptive or balancing selection. Such proposals predict long-range linkage disequilibrium (LD) resulting from a selective sweep, although genetic drift in a founder population may also act to create long-distance LD. To date, few studies have used the tools of statistical genomics to examine the likelihood of long-range LD at a deleterious locus in a population that faced a genetic bottleneck. We studied the genotypes of hundreds of women from a large international consortium of BRCA1 and BRCA2 mutation carriers and found that AJ women exhibited long-range haplotypes compared to CNJ women. More than 50% of the AJ chromosomes with the BRCA1 185delAG mutation share an identical 2.1 Mb haplotype and nearly 16% of AJ chromosomes carrying the BRCA2 6174delT mutation share a 1.4 Mb haplotype. Simulations based on the best inference of Ashkenazi population demography indicate that long-range haplotypes are expected in the context of a genome-wide survey. Our results are consistent with the hypothesis that a local bottleneck effect from population size constriction events could by chance have resulted in the large haplotype blocks observed at high frequency in the BRCA1 and BRCA2 regions of Ashkenazi Jews.
引用
收藏
页码:685 / 699
页数:15
相关论文
共 38 条
[1]   Interrogating a high-density SNP map for signatures of natural selection [J].
Akey, JM ;
Zhang, G ;
Zhang, K ;
Jin, L ;
Shriver, MD .
GENOME RESEARCH, 2002, 12 (12) :1805-1814
[2]  
[Anonymous], 2007, PRINCIPLES POPULATIO
[3]   Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction [J].
Antoniou, Antonis C. ;
Beesley, Jonathan ;
McGuffog, Lesley ;
Sinilnikova, Olga M. ;
Healey, Sue ;
Neuhausen, Susan L. ;
Ding, Yuan Chun ;
Rebbeck, Timothy R. ;
Weitzel, Jeffrey N. ;
Lynch, Henry T. ;
Isaacs, Claudine ;
Ganz, Patricia A. ;
Tomlinson, Gail ;
Olopade, Olufunmilayo I. ;
Couch, Fergus J. ;
Wang, Xianshu ;
Lindor, Noralane M. ;
Pankratz, Vernon S. ;
Radice, Paolo ;
Manoukian, Siranoush ;
Peissel, Bernard ;
Zaffaroni, Daniela ;
Barile, Monica ;
Viel, Alessandra ;
Allavena, Anna ;
Dall'Olio, Valentina ;
Peterlongo, Paolo ;
Szabo, Csilla I. ;
Zikan, Michal ;
Claes, Kathleen ;
Poppe, Bruce ;
Foretova, Lenka ;
Mai, Phuong L. ;
Greene, Mark H. ;
Rennert, Gad ;
Lejbkowicz, Flavio ;
Glendon, Gord ;
Ozcelik, Hilmi ;
Andrulis, Irene L. ;
Thomassen, Mads ;
Gerdes, Anne-Marie ;
Sunde, Lone ;
Cruger, Dorthe ;
Jensen, Uffe Birk ;
Caligo, Maria ;
Friedman, Eitan ;
Kaufman, Bella ;
Laitman, Yael ;
Milgrom, Roni ;
Dubrovsky, Maya .
CANCER RESEARCH, 2010, 70 (23) :9742-9754
[4]   Abraham's Children in the Genome Era: Major Jewish Diaspora Populations Comprise Distinct Genetic Clusters with Shared Middle Eastern Ancestry [J].
Atzmon, Gil ;
Hao, Li ;
Pe'er, Itsik ;
Velez, Christopher ;
Pearlman, Alexander ;
Palamara, Pier Francesco ;
Morrow, Bernice ;
Friedman, Eitan ;
Oddoux, Carole ;
Burns, Edward ;
Ostrer, Harry .
AMERICAN JOURNAL OF HUMAN GENETICS, 2010, 86 (06) :850-859
[5]   Haploview: analysis and visualization of LD and haplotype maps [J].
Barrett, JC ;
Fry, B ;
Maller, J ;
Daly, MJ .
BIOINFORMATICS, 2005, 21 (02) :263-265
[6]   Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population [J].
Bray, Steven M. ;
Mulle, Jennifer G. ;
Dodd, Anne F. ;
Pulver, Ann E. ;
Wooding, Stephen ;
Warren, Stephen T. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (37) :16222-16227
[7]   Genomic regions exhibiting positive selection identified from dense genotype data [J].
Carlson, CS ;
Thomas, DJ ;
Eberle, MA ;
Swanson, JE ;
Livingston, RJ ;
Rieder, MJ ;
Nickerson, DA .
GENOME RESEARCH, 2005, 15 (11) :1553-1565
[8]  
CHAKRAVARTI A, 1978, AM J HUM GENET, V30, P256
[9]   An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers:: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2(CIMBA) [J].
Chenevix-Trench, Georgia ;
Milne, Roger L. ;
Antoniou, Antonis C. ;
Couch, Fergus J. ;
Easton, Douglas F. ;
Goldgar, David E. .
BREAST CANCER RESEARCH, 2007, 9 (02)
[10]  
Clayton D.G., SNPHAP: A program for estimating frequencies of large haplotypes of SNPs. Version 1.3.1